This inventor holds 1 USPTO granted patent and 8 published patent applications and 1 EPO patent. Top assignee: Fudan University. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Inventor Jie Pan and His Contributions to Anti-Tumor Research
Introduction
Jie Pan, a dedicated inventor based in Shanghai, China, has made significant strides in the field of medical technology. He holds a patent dedicated to the application of cyclic dinucleotide (cGAMP) in the anti-tumor sector. This groundbreaking invention presents a novel approach to combating tumor growth while minimizing toxicity.
Latest Patents
Jie Pan's notable invention revolves around the application of cyclic dinucleotide (cGAMP) for tumor treatment. Research indicates that cGAMP can effectively inhibit the growth of various tumor cells, demonstrating remarkable anti-tumor effects. This potential has opened new avenues for the preparation of anti-tumor drugs, which exhibit low toxicity while providing favorable therapeutic outcomes. Notably, studies conducted on subcutaneous tumor models in nude mice reveal that cGAMP significantly inhibits tumors associated with several human cancer cell lines, including gastric, lung, colorectal, hepatocellular, prostatic, and pancreatic carcinomas.
Career Highlights
Jie Pan is currently affiliated with Fudan University, where he contributes to advanced research in oncology and medical technology. His commitment to innovation has positioned him as an influential figure in his field, and his patent stands as a testament to his expertise and dedication to healthcare advancements.
Collaborations
Throughout his career, Jie Pan has collaborated with esteemed colleagues, including Xiangshi Tan and Tiejun Li. This teamwork has fostered an environment of shared knowledge and expertise, further enhancing their collective impact on cancer research and treatment methodologies.
Conclusion
Jie Pan is an exemplary inventor whose work in the application of cyclic dinucleotide (cGAMP) represents a promising leap forward in anti-tumor treatments. His contributions to medical technology demonstrate the importance of innovation in the fight against cancer, and he continues to inspire others in the realm of research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
